Video Experimental Relacionado
Updated: Sep 10, 2025
23:53
Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
8.1K
¿Qué medicamentos necesitan las personas con enfermedad de Parkinson?
Kevin McFarthing1, Tiago Fleming Outeiro2,3, Maria Carmo Bastos4
1Parkinson's Research Advocate, Oxford, UK.
Journal of Parkinson's disease
|August 26, 2025
Resumen
Las personas con enfermedad de Parkinson (EP) desean medicamentos personalizados que controlen los síntomas y ralenticen la progresión. Las necesidades de los pacientes, centradas en la calidad de vida y la comodidad, deben guiar el desarrollo de nuevos tratamientos para la enfermedad de Parkinson.
Área de la Ciencia:
- La neurociencia
- Farmacología
- Investigación centrada en el paciente
Sus antecedentes:
- La enfermedad de Parkinson (EP) es un trastorno neurológico complejo con una heterogeneidad significativa en su presentación clínica, patología y progresión.
- Comprender las necesidades del paciente es crucial para desarrollar tratamientos efectivos para la enfermedad de Parkinson.
Objetivo del estudio:
- Explorar las características deseadas de los medicamentos para las personas con Parkinson (PwP).
- Para enfatizar la importancia de enfoques centrados en el paciente en el desarrollo de fármacos para la enfermedad de Parkinson.
Principales métodos:
- Análisis cualitativo de las perspectivas de los pacientes sobre los atributos deseados de la medicación.
- Revisión de las estrategias terapéuticas actuales y potenciales para la enfermedad de Parkinson, incluidos los tratamientos sintomáticos (ST) y modificadores de la enfermedad (DMT).
Principales resultados:
- PwP da prioridad a los medicamentos que ofrecen una eficacia, comodidad y asequibilidad óptimas.
- Los síntomas molestos informados por los pacientes son objetivos clave para la intervención terapéutica.
- El diagnóstico temprano y el tratamiento pre-sintomático son prometedores para detener la progresión de la EP.
Conclusiones:
- La futura farmacopea de la enfermedad de Parkinson debe centrarse en cócteles de tratamiento personalizados.
- La colaboración entre los investigadores y PwP es esencial para alinear el desarrollo de fármacos con las necesidades de los pacientes y mejorar la calidad de vida.
- Comunicar el potencial de tratamiento realista es vital para mantener la esperanza en la comunidad de Parkinson.
Videos de Conceptos Relacionados
01:24Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
01:28Drug Therapy
97
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
97
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:26Cholinergic Antagonists: Therapeutic Uses
871
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
871
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
380
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
380